ID=wsj_1934.1 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT A NP[nb]_149/N_149>) (<T N 1 2> (<L N/N JJ JJ new N_144/N_144>) (<L N NN NN drug N>) ) ) (<T NP\NP 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_158)/(S[b]_159\NP_158:B)_159>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB prevent (S[b]\NP_166)/NP_167>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_174/N_174>) (<L N NN NN rejection N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_182\NP_182)/NP_183>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ transplanted N_192/N_192>) (<L N NNS NNS organs N>) ) ) ) ) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_10)/(S[pt]_11\NP_10:B)_11>) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/(S[pss]\NP) VBN VBN been (S[pt]\NP_20)/(S[pss]_21\NP_20:B)_21>) (<T S[pss]\NP 1 2> (<L (S\NP)/(S\NP) RB RB successfully (S_135\NP_130)_135/(S_135\NP_130)_135>) (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/PP VBN VBN used (S[pss]\NP_28)/PP_29>) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_34>) (<T NP 0 1> (<T N 1 2> (<T N/N 1 2> (<T (N/N)/(N/N) 1 2> (<L S[adj]\NP JJR JJR more S[adj]\NP_65>) (<L ((N/N)/(N/N))\(S[adj]\NP) IN IN than ((N_59/N_51)_59/(N_59/N_51)_59)\(S[adj]_60\NP_54)_60>) ) (<L N/N CD CD 100 N_43/N_43>) ) (<L N NNS NNS patients N>) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN at ((S_79\NP_74)_79\(S_79\NP_74)_79)/NP_80>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_87/N_87>) (<L N NNP NNP University N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_95\NP_95)/NP_96>) (<T NP 0 1> (<L N NNP NNP Pittsburgh N>) ) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/PP VBG VBG according ((S_114\NP_109)_114\(S_114\NP_109)_114)/PP_115>) (<T PP 0 2> (<L PP/NP TO TO to PP/NP_120>) (<T NP 0 1> (<L N NNS NNS researchers N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.2 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_256/N_256>) (<L N NN NN drug N>) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_268\NP_268)/(S[dcl]_269\NP_268:B)_269>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L (S[dcl]\NP)/PP VBZ VBZ is (S[dcl]\NP_276)/PP_277>) (<L (S\NP)\(S\NP) RB RB still (S_289\NP_284)_289\(S_289\NP_284)_289>) ) (<T PP 0 2> (<L PP/NP IN IN in PP/NP_294>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_308/N_308>) (<T N 1 2> (<L N/N JJ JJ experimental N_303/N_303>) (<L N NN NN phase N>) ) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[pt]\NP) 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_177)/(S[pt]_178\NP_177:B)_178>) (<L (S\NP)\(S\NP) RB RB n't (S_190\NP_185)_190\(S_190\NP_185)_190>) ) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/(S[pss]\NP) VBN VBN been (S[pt]\NP_199)/(S[pss]_200\NP_199:B)_200>) (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN approved S[pss]\NP_205>) (<L (S\NP)\(S\NP) RB RB yet (S_217\NP_212)_217\(S_217\NP_212)_217>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_230\NP_225)_230\(S_230\NP_225)_230)/NP_231>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_249/N_249>) (<T N 1 2> (<L N NNP NNP Food N>) (<T N[conj] 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N NNP NNP Drug N_240/N_240>) (<L N NNP NNP Admistration N>) ) ) ) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC and conj>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ its NP[nb]_339/N_339>) (<T N 1 2> (<L N/N JJ JJ long-term N_334/N_334>) (<L N NNS NNS effects N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[adj]\NP) VBP VBP are (S[dcl]\NP_319)/(S[adj]_320\NP_319:B)_320>) (<L S[adj]\NP JJ JJ unknown S[adj]\NP_325>) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.3 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_310/S_310>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS researchers N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBP VBP say (S[dcl]\NP_163)/S[dcl]_164>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_280/N_280>) (<L N NN NN drug N>) ) (<L , , , , ,>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/NP VBD VBN called (S[pss]\NP_289)/NP_290>) (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD could (S[dcl]\NP_173)/(S[b]_174\NP_173:B)_174>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB revolutionize (S[b]\NP_181)/NP_182>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_196/N_196>) (<T N 1 2> (<L N/N NN NN transplantation N_191/N_191>) (<L N NN NN field N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/(S[ng]\NP) IN IN by ((S_211\NP_204)_211\(S_211\NP_204)_211)/(S[ng]_212\NP_204:B)_212>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG reducing (S[ng]\NP_219)/NP_220>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ harmful N_236/N_236>) (<T N 1 2> (<L N/N JJ JJ side N_229/N_229>) (<L N NNS NNS effects N>) ) ) ) ) ) (<T (S\NP)\(S\NP)[conj] 1 2> (<L conj CC CC and conj>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/(S[ng]\NP) IN IN by ((S_252\NP_245)_252\(S_252\NP_245)_252)/(S[ng]_253\NP_245:B)_253>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG lowering (S[ng]\NP_260)/NP_261>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN rejection N_270/N_270>) (<L N NNS NNS rates N>) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.4 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NN NN Rejection N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_137)/(S[pt]_138\NP_137:B)_138>) (<T S[pt]\NP 0 2> (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/NP VBN VBN been (S[pt]\NP_145)/NP_146>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_160/N_160>) (<T N 1 2> (<L N/N JJ JJ major N_155/N_155>) (<L N NN NN obstacle N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_173\NP_168)_173\(S_173\NP_168)_173)/NP_174>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_209/N_209>) (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) RB RB approximately (N_204/N_198)_204/(N_204/N_198)_204>) (<L N/N CD CD 30,000 N_190/N_190>) ) (<T N 1 2> (<L N/N NN NN organ N_183/N_183>) (<L N NNS NNS transplants N>) ) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN performed S[pss]\NP_214>) (<L (S\NP)\(S\NP) RB RB world-wide (S_226\NP_221)_226\(S_226\NP_221)_226>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/N DT DT each ((S_239\NP_234)_239\(S_239\NP_234)_239)/N_240>) (<L N NN NN year N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.5 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS Researchers N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<T (S[dcl]\NP)/PP 0 2> (<L ((S[dcl]\NP)/PP)/(S[ng]\NP) VBD VBD began ((S[dcl]\NP_120)/PP_121)/(S[ng]_122\NP_120:B)_122>) (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/NP VBG VBG using (S[ng]\NP_129)/NP_130>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_137/N_137>) (<L N NN NN drug N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_150\NP_145)_150\(S_150\NP_145)_150)/NP_151>) (<T NP 0 1> (<L N NNP NNP February N>) ) ) ) (<T PP 0 2> (<L PP/NP IN IN on PP/NP_159>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS patients N>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WP WP who (NP_172\NP_172)/(S[dcl]_173\NP_172:B)_173>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBD VBD had (S[dcl]\NP_182)/(S[pt]_183\NP_182:B)_183>) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/NP VBN VBN received (S[pt]\NP_190)/NP_191>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN kidney N_227/N_227>) (<T N 1 2> (<L , , , , ,>) (<T N 1 2> (<L N/N NN NN liver N_218/N_218>) (<T N 1 2> (<L , , , , ,>) (<T N 1 2> (<L N/N NN NN heart N_209/N_209>) (<T N 1 2> (<L conj CC CC and conj>) (<T N 1 2> (<L N/N NN NN pancreas N_200/N_200>) (<L N NNS NNS transplants N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.6 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N RB RB Only N_156/N_156>) (<T N 0 2> (<L N CD CD two N>) (<T N\N 0 2> (<L (N\N)/NP IN IN of (N_138\N_138)/NP_139>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 111 N_148/N_148>) (<L N NNS NNS transplants N>) ) ) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP have (S[dcl]\NP_112)/(S[pt]_113\NP_112:B)_113>) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/(S[pss]\NP) VBN VBN been (S[pt]\NP_122)/(S[pss]_123\NP_122:B)_123>) (<L S[pss]\NP VBN VBN rejected S[pss]\NP_128>) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.7 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_116/N_116>) (<L N NN NN drug N>) ) (<L , , , , ,>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN discovered S[pss]\NP_123>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_136\NP_131)_136\(S_136\NP_131)_136)/NP_137>) (<T NP 0 1> (<L N CD CD 1984 N>) ) ) ) ) ) (<L , , , , ,>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBZ VBZ is (S[dcl]\NP_58)/(S[pss]_59\NP_58:B)_59>) (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/PP VBN VBN metabolized (S[pss]\NP_66)/PP_67>) (<T PP 0 2> (<L PP/NP IN IN from PP/NP_72>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN soil N_81/N_81>) (<L N NN NN fungus N>) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN found S[pss]\NP_87>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_100\NP_95)_100\(S_100\NP_95)_100)/NP_101>) (<T NP 0 1> (<L N NNP NNP Japan N>) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.8 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_209/N_209>) (<T N 1 2> (<L N/N NNP NNP Pittsburgh N_204/N_204>) (<L N NNS NNS patients N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBP VBP are (S[dcl]\NP_81)/NP_82>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_96/N_96>) (<T N 1 2> (<L N/N JJ JJ first N_91/N_91>) (<L N NNS NNS humans N>) ) ) (<T NP\NP 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_105)/(S[b]_106\NP_105:B)_106>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[pss]\NP) VB VB be (S[b]\NP_115)/(S[pss]_116\NP_115:B)_116>) (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/NP VBN VBN given (S[pss]\NP_123)/NP_124>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_131/N_131>) (<L N NN NN drug N>) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_143\NP_143)/(S[dcl]_144\NP_143:B)_144>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBZ VBZ is (S[dcl]\NP_153)/(S[pss]_154\NP_153:B)_154>) (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN made S[pss]\NP_159>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_172\NP_167)_172\(S_172\NP_167)_172)/NP_173>) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Fujisawa N_189/N_189>) (<T N 1 2> (<L N/N NNP NNP Pharmaceutical N_182/N_182>) (<L N NNP NNP Co N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.9 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 1 2> (<T S[dcl] 1 2> (<L NP PRP PRP We NP>) (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP 're (S[dcl]\NP_257)/(S[pt]_258\NP_257:B)_258>) (<T S[pt]\NP 0 2> (<L S[pt]\NP VBN JJ shocked S[pt]\NP_263>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_276\NP_271)_276\(S_276\NP_271)_276)/NP_277>) (<L NP PRP PRP it NP>) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/S[dcl] IN IN because ((S_294\NP_289)_294\(S_294\NP_289)_294)/S[dcl]_295>) (<T S[dcl] 1 2> (<L NP PRP PRP it NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ 's (S[dcl]\NP_304)/(S[pt]_305\NP_304:B)_305>) (<T S[pt]\NP 0 2> (<L S[pt]\NP VBN VBN worked S[pt]\NP_310>) (<T (S\NP)\(S\NP) 1 2> (<L ((S\NP)\(S\NP))/((S\NP)\(S\NP)) RB RB so ((S_345\NP_337)_345\(S_338\NP_337)_338)_345/((S_345\NP_337)_345\(S_338\NP_337)_338)_345>) (<L (S\NP)\(S\NP) RB RB fast (S_322\NP_317)_322\(S_322\NP_317)_322>) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<L (S[dcl]\S[dcl])/NP VBD VBD said (S[dcl]\S[dcl]_127)/NP_128>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_151/N_151>) (<T N 1 2> (<L N/N NNP NNP Thomas N_144/N_144>) (<T N 1 2> (<L N/N NNP NNP E. N_137/N_137>) (<L N NNP NNP Starzl N>) ) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN director N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_163\NP_163)/NP_164>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_203/N_203>) (<T N 1 2> (<T N/N 0 2> (<L N/N NNP NNP University N_180/N_180>) (<T (N/N)\(N/N) 0 2> (<L ((N/N)\(N/N))/NP IN IN of ((N_194/N_188)_194\(N_194/N_188)_194)/NP_195>) (<T NP 0 1> (<L N NNP NNP Pittsburgh N>) ) ) ) (<T N 1 2> (<L N/N NNP NNP Transplantation N_173/N_173>) (<L N NNP NNP Program N>) ) ) ) ) ) ) ) (<L , , , , ,>) ) ) (<T S\S 0 2> (<L (S\S)/NP IN IN at (S_215\S_215)/NP_216>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_230/N_230>) (<T N 1 2> (<L N/N NN NN news N_225/N_225>) (<L N NN NN conference N>) ) ) ) ) (<L S\S RB RB here S_237\S_237>) ) (<L S\S NN NN yesterday S_244\S_244>) ) (<L . . . . .>) ) ) ) 
ID=wsj_1934.10 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 1 2> (<T S[dcl] 1 2> (<L NP PRP PRP We NP>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/NP 0 2> (<L ((S[dcl]\NP)/NP)/NP VBP VBP consider ((S[dcl]\NP_276)/NP_277)/NP_278>) (<L NP PRP PRP it NP>) ) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_294/N_294>) (<T N 1 2> (<L N/N JJ JJ life-saving N_289/N_289>) (<L N NN NN drug N>) ) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN like (NP_304\NP_304)/NP_305>) (<T NP 0 2> (<T NP 0 1> (<L N CD CD one N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_316\NP_316)/NP_317>) (<T NP 0 1> (<L N NNP NNP AIDS N>) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 0 2> (<T S[dcl]\S[dcl] 0 2> (<L (S[dcl]\S[dcl])/NP VBD VBD said (S[dcl]\S[dcl]_208)/NP_209>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_225/N_225>) (<T N 1 2> (<L N/N NNP NNP John N_218/N_218>) (<L N NNP NNP Fung N>) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT an NP[nb]_233/N_233>) (<L N NN NN immunologist N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN at (NP_241\NP_241)/NP_242>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_249/N_249>) (<L N NNP NNP University N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_257\NP_257)/NP_258>) (<T NP 0 1> (<L N NNP NNP Pittsburgh N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) ) ) 
ID=wsj_1934.11 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS Researchers N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBP VBP say (S[dcl]\NP_99)/S[dcl]_100>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBP VBP believe (S[dcl]\NP_107)/S[dcl]_108>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[adj]\NP) VBZ VBZ is (S[dcl]\NP_117)/(S[adj]_118\NP_117:B)_118>) (<T S[adj]\NP 0 2> (<T S[adj]\NP 1 2> (<T (S[adj]\NP)/(S[adj]\NP) 1 2> (<L ((S[adj]\NP)/(S[adj]\NP))/((S[adj]\NP)/(S[adj]\NP)) CD CD 100 ((S[adj]_170\NP_162)_170/(S[adj]_163\NP_162)_163)_170/((S[adj]_170\NP_162)_170/(S[adj]_163\NP_162)_163)_170>) (<L (S[adj]\NP)/(S[adj]\NP) NNS NNS times (S[adj]_147\NP_142)_147/(S[adj]_147\NP_142)_147>) ) (<T S[adj]\NP 1 2> (<L (S[adj]\NP)/(S[adj]\NP) RBR RBR more (S[adj]_135\NP_130)_135/(S[adj]_135\NP_130)_135>) (<L S[adj]\NP JJ JJ effective S[adj]\NP_123>) ) ) (<T (S[adj]\NP)\(S[adj]\NP) 0 2> (<L ((S[adj]\NP)\(S[adj]\NP))/NP IN IN than ((S[adj]_183\NP_178)_183\(S[adj]_183\NP_178)_183)/NP_184>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_205/N_205>) (<T N 1 2> (<L N/N JJ JJ traditional N_200/N_200>) (<T N 1 2> (<L N/N JJ JJ anti-rejection N_193/N_193>) (<L N NN NN drug N>) ) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 1> (<L N NN NN cyclosporine N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN made S[pss]\NP_217>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_230\NP_225)_230\(S_230\NP_225)_230)/NP_231>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ Swiss N_261/N_261>) (<T N 1 2> (<L N/N JJ JJ pharmaceutical N_254/N_254>) (<T N 1 2> (<L N/N NN NN giant N_247/N_247>) (<T N 1 2> (<L N/N NNP NNP Sandoz N_240/N_240>) (<L N NNP NNP Ltd N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.12 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP They NP>) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[pss]\NP) 0 2> (<L (S[dcl]\NP)/(S[pss]\NP) VBP VBP are (S[dcl]\NP_168)/(S[pss]_169\NP_168:B)_169>) (<L (S\NP)\(S\NP) RB RB also (S_181\NP_176)_181\(S_181\NP_176)_181>) ) (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN encouraged S[pss]\NP_186>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_199\NP_194)_199\(S_199\NP_194)_199)/NP_200>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_235/N_235>) (<T N 1 2> (<T N/N 1 2> (<L (N/N)/(N/N) RB RB relatively (N_230/N_224)_230/(N_230/N_224)_230>) (<L N/N JJ JJ mild N_216/N_216>) ) (<T N 1 2> (<L N/N JJ JJ side N_209/N_209>) (<L N NNS NNS effects N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_243\NP_243)/NP_244>) (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/PP VBN VBN compared (NP_257\NP_257)/PP_258>) (<T PP 0 2> (<L PP/NP IN IN with PP/NP_263>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NN NN cyclosporine N>) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_278\NP_278)/(S[dcl]_279\NP_278:B)_279>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD can (S[dcl]\NP_288)/(S[b]_289\NP_288:B)_289>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB cause (S[b]\NP_296)/NP_297>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ renal N_306/N_306>) (<L N NN NN failure N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN morbidity N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN nausea N>) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ other N_322/N_322>) (<L N NNS NNS problems N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.13 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_238/N_238>) (<T N 1 2> (<L N/N JJ JJ side N_233/N_233>) (<L N NNS NNS effects N>) ) ) (<T NP\NP 0 2> (<T NP\NP 1 2> (<L LRB LRB -LRB- -LCB- LRB>) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_246\NP_246)/NP_247>) (<T NP 0 1> (<L N NN NN cyclosporine N>) ) ) ) (<L RRB RRB -RRB- -RCB- RRB>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP have (S[dcl]\NP_170)/(S[pt]_171\NP_170:B)_171>) (<T S[pt]\NP 0 2> (<T (S[pt]\NP)/(S[adj]\NP) 0 2> (<L ((S[pt]\NP)/(S[adj]\NP))/NP VBN VBN made ((S[pt]\NP_182)/(S[adj]_183\NP_184:B)_183)/NP_184>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_191/N_191>) (<L N NN NN penalty N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_199\NP_199)/NP_200>) (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ its NP[nb]_207/N_207>) (<L N NN NN success N>) ) ) ) ) (<T S[adj]\NP 1 2> (<L (S[adj]\NP)/(S[adj]\NP) RB RB rather (S[adj]_224\NP_219)_224/(S[adj]_224\NP_219)_224>) (<L S[adj]\NP JJ JJ high S[adj]\NP_212>) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_158/N_158>) (<L N NNP NNP Starzl N>) ) ) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_148)\NP_149>) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.14 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_295/N_295>) (<L N NNP NNP Fung N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[em] VBD VBD said (S[dcl]\NP_103)/S[em]_104>) (<T S[em] 0 2> (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_109>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_118)/(S[b]_119\NP_118:B)_119>) (<L (S\NP)\(S\NP) RB RB not (S_131\NP_126)_131\(S_131\NP_126)_131>) ) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[adj]\NP) VB VB be (S[b]\NP_140)/(S[adj]_141\NP_140:B)_141>) (<L S[adj]\NP JJ JJ available S[adj]\NP_146>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN in ((S_159\NP_154)_159\(S_159\NP_154)_159)/NP_160>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_167/N_167>) (<L N NN NN market N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN for ((S_180\NP_175)_180\(S_180\NP_175)_180)/NP_181>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP/NP 0 2> (<L (NP/NP)/(S[asup]\NP) IN IN at (NP_198/NP_198)/(S[asup]_199\NP_195)_199>) (<L S[asup]\NP JJS JJS least S[asup]\NP_204>) ) (<L NP[nb]/N DT DT a NP[nb]_188/N_188>) ) (<L N NN NN year N>) ) ) ) ) ) ) (<T S[em][conj] 1 2> (<L , , , , ,>) (<T S[em][conj] 1 2> (<L conj CC CC and conj>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_212>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_282/N_282>) (<T N 1 2> (<L N/N NNP NNP FDA N_277/N_277>) (<T N 1 2> (<L N/N NN NN approval N_270/N_270>) (<L N NN NN process N>) ) ) ) (<T S[dcl]\NP 1 2> (<L (S\NP)/(S\NP) RB RB usually (S_261\NP_256)_261/(S_261\NP_256)_261>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ takes (S[dcl]\NP_219)/NP_220>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD three N_229/N_229>) (<L N NNS NNS years N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP CC TO to (NP_238\NP_238)/NP_239>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD five N_248/N_248>) (<L N NNS NNS years N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.15 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP[thr] EX EX There NP[thr]>) (<T S[dcl]\NP[thr] 0 2> (<L (S[dcl]\NP[thr])/NP VBP VBP are (S[dcl]\NP[thr]_181)/NP_182>) (<T NP 1 2> (<L NP[nb]/N DT DT no NP[nb]_322/N_322>) (<T N 1 2> (<L N/N JJ JJ firm N_317/N_317>) (<T N 0 2> (<L N NNS NNS plans N>) (<T N\N 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_193)/(S[b]_194\NP_193:B)_194>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB expand (S[b]\NP_201)/NP_202>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_216/N_216>) (<T N 1 2> (<L N/N JJ JJ experimental N_211/N_211>) (<L N NN NN program N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN beyond ((S_229\NP_224)_229\(S_229\NP_224)_229)/NP_230>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_237/N_237>) (<L N NNP NNP University N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_245\NP_245)/NP_246>) (<T NP 0 1> (<L N NNP NNP Pittsburgh N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 2> (<T (NP\NP)/(S[dcl]\NP) 0 2> (<L ((NP\NP)/(S[dcl]\NP))/N WP$ WP$ whose ((NP_263\NP_263)/(S[dcl]_264\N_265:B)_264)/N_265>) (<L N NN NN hospital N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ performs (S[dcl]\NP_274)/NP_275>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_289/N_289>) (<T N 1 2> (<L N/N JJS JJS most N_284/N_284>) (<L N NNS NNS transplants N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_297\NP_297)/NP_298>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_305/N_305>) (<L N NN NN world N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.16 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS Researchers N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD could (S[dcl]\NP_136)/(S[b]_137\NP_136:B)_137>) (<L (S\NP)\(S\NP) RB RB n't (S_149\NP_144)_149\(S_149\NP_144)_149>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB estimate (S[b]\NP_156)/NP_157>) (<T NP 0 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_164/N_164>) (<L N NN NN cost N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_172\NP_172)/NP_173>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_180/N_180>) (<L N NN NN drug N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/S[dcl] WRB WRB when (NP_188\NP_188)/S[dcl]_189>) (<T S[dcl] 1 2> (<L NP PRP PRP it NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ reaches (S[dcl]\NP_196)/NP_197>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_204/N_204>) (<L N NN NN market N>) ) ) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC but conj>) (<T S[dcl] 1 2> (<L NP PRP PRP they NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_216)/S[dcl]_217>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD will (S[dcl]\NP_226)/(S[b]_227\NP_226:B)_227>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T (S[b]\NP)/(S[to]\NP) 0 2> (<L ((S[b]\NP)/(S[to]\NP))/NP VB VB enable ((S[b]\NP_238)/(S[to]_239\NP_240:B)_239)/NP_240>) (<T NP 0 1> (<L N NNS NNS patients N>) ) ) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_252)/(S[b]_253\NP_252:B)_253>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB cut (S[b]\NP_260)/NP_261>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN hospital N_270/N_270>) (<L N NNS NNS stays N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_284\NP_279)_284\(S_284\NP_279)_284)/NP_285>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD 50 N_294/N_294>) (<L N NN NN % N>) ) ) ) ) ) ) (<T S[b]\NP[conj] 1 2> (<L conj CC CC and conj>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB reduce (S[b]\NP_302)/NP_303>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_310/N_310>) (<L N NN NN number N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_318\NP_318)/NP_319>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NN NN blood N_328/N_328>) (<L N NNS NNS tests N>) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/(S[to]\NP) VBN VBN used (S[pss]\NP_338)/(S[to]_339\NP_338:B)_339>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_348)/(S[b]_349\NP_348:B)_349>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB monitor (S[b]\NP_356)/NP_357>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_364/N_364>) (<L N NN NN dosage N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_372\NP_372)/NP_373>) (<T NP 0 2> (<T NP 0 1> (<L N NN JJ cyclosporine N>) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ other N_385/N_385>) (<L N NNS NNS drugs N>) ) ) ) ) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN among ((S_401\NP_396)_401\(S_401\NP_396)_401)/NP_402>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN transplant N_411/N_411>) (<L N NNS NNS recipients N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.17 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_434/N_434>) (<L N NNP NNP Starzl N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_255)/S[dcl]_256>) (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_366/N_366>) (<L N NN NN research N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_265)/(S[pt]_266\NP_265:B)_266>) (<T S[pt]\NP 0 2> (<T (S[pt]\NP)/(S[pss]\NP) 0 2> (<L (S[pt]\NP)/(S[pss]\NP) VBN VBN been (S[pt]\NP_275)/(S[pss]_276\NP_275:B)_276>) (<L (S\NP)\(S\NP) RB RB largely (S_288\NP_283)_288\(S_288\NP_283)_288>) ) (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN financed S[pss]\NP_293>) (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_306\NP_301)_306\(S_306\NP_301)_306)/NP_307>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_321/N_321>) (<T N 1 2> (<L N/N NNP NNP National N_316/N_316>) (<L N NNP NNP Institute N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_329\NP_329)/NP_330>) (<T NP 0 1> (<L N NNP NNP Health N>) ) ) ) ) (<T (S\NP)\(S\NP)[conj] 1 2> (<L conj CC CC and conj>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_346\NP_341)_346\(S_346\NP_341)_346)/NP_347>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN university N_356/N_356>) (<L N NNS NNS funds N>) ) ) ) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC and conj>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_371>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Fujisawa N>) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) VBD VBD did (S[dcl]\NP_380)/(S[b]_381\NP_380:B)_381>) (<L (S\NP)\(S\NP) RB RB n't (S_393\NP_388)_393\(S_393\NP_388)_393>) ) (<T S[b]\NP 0 2> (<T (S[b]\NP)/NP 0 2> (<L ((S[b]\NP)/NP)/NP VB VB give ((S[b]\NP_402)/NP_403)/NP_404>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_411/N_411>) (<L N NN NN hospital N>) ) ) (<T NP 1 2> (<L NP[nb]/N DT DT any NP[nb]_418/N_418>) (<L N NNS NNS grants N>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.18 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP He NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[em] VBD VBD said (S[dcl]\NP_169)/S[em]_170>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_175>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_227/N_227>) (<T N 1 2> (<L N/N NN NN research N_222/N_222>) (<L N NN NN team N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD had (S[dcl]\NP_182)/NP_183>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT no NP[nb]_197/N_197>) (<T N 1 2> (<L N/N JJ JJ financial N_192/N_192>) (<L N NN NN stake N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN in (NP_205\NP_205)/NP_206>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_213/N_213>) (<L N NN NN drug N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1934.19 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L NP PRP PRP We NP>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBP VBP 've (S[dcl]\NP_163)/(S[pt]_164\NP_163:B)_164>) (<T S[pt]\NP 0 2> (<T (S[pt]\NP)/NP 0 2> (<L (S[pt]\NP)/NP VBN VBN known (S[pt]\NP_171)/NP_172>) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN for ((S_185\NP_180)_185\(S_185\NP_180)_185)/NP_186>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD six N_195/N_195>) (<L N NNS NNS months N>) ) ) ) ) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_203/N_203>) (<L N NN NN effect N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_211\NP_211)/NP_212>) (<T NP 1 2> (<L NP[nb]/N DT DT this NP[nb]_219/N_219>) (<L N NN NN drug N>) ) ) ) ) ) ) (<T S[dcl][conj] 1 2> (<L , , , , ,>) (<T S[dcl][conj] 1 2> (<L conj CC CC and conj>) (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ our NP[nb]_295/N_295>) (<L N NN NN advice N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP TO TO to (NP_303\NP_303)/NP_304>) (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ our NP[nb]_311/N_311>) (<L N NNS NNS people N>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[pt]\NP) VBZ VBZ has (S[dcl]\NP_230)/(S[pt]_231\NP_230:B)_231>) (<T S[pt]\NP 0 2> (<L (S[pt]\NP)/(S[to]\NP) VBN VBN been (S[pt]\NP_240)/(S[to]_241\NP_240:B)_241>) (<T S[to]\NP 1 2> (<L (S\NP)/(S\NP) RB RB not (S_288\NP_283)_288/(S_288\NP_283)_288>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_250)/(S[b]_251\NP_250:B)_251>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB buy (S[b]\NP_258)/NP_259>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_276/N_276>) (<L N NN NN company N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_268/N_268)\NP_269>) ) (<L N NN NN stock N>) ) ) ) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Dr. N_151/N_151>) (<L N NNP NNP Starzl N>) ) ) (<T (S[dcl]\S[dcl])\NP 0 2> (<T (S[dcl]\S[dcl])\NP 0 2> (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_67)\NP_68>) (<L , , , , ,>) ) (<T S\S 0 1> (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/S[em] VBG VBG adding (S[ng]\NP_77)/S[em]_78>) (<T S[em] 0 2> (<L S[em]/S[dcl] IN IN that S[em]/S[dcl]_83>) (<T S[dcl] 1 2> (<T NP 0 1> (<T S[ng]\NP 0 2> (<L (S[ng]\NP)/PP VBG VBG profiting (S[ng]\NP_127)/PP_128>) (<T PP 0 2> (<L PP/NP IN IN from PP/NP_133>) (<T NP 0 1> (<L N NNP NNP FK-506 N>) ) ) ) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_92)/(S[b]_93\NP_92:B)_93>) (<L (S\NP)\(S\NP) RB RB n't (S_105\NP_100)_105\(S_105\NP_100)_105>) ) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[adj]\NP) VB VB be (S[b]\NP_114)/(S[adj]_115\NP_114:B)_115>) (<L S[adj]\NP JJ JJ ethical S[adj]\NP_120>) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
